The double‐edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza‐associated mucormycosis versus …
K Ahmadikia, SJ Hashemi, S Khodavaisy, MI Getso… - Mycoses, 2021 - Wiley Online Library
Acute respiratory distress syndrome is a common complication of severe viral pneumonia,
such as influenza and COVID‐19, that requires critical care including ventilatory support …
such as influenza and COVID‐19, that requires critical care including ventilatory support …
The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis
YN Ni, G Chen, J Sun, BM Liang, ZA Liang - Critical care, 2019 - Springer
Background The effect of corticosteroids on clinical outcomes in patients with influenza
pneumonia remains controversial. We aimed to further evaluate the influence of …
pneumonia remains controversial. We aimed to further evaluate the influence of …
Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX …
Importance Acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019
(COVID-19) is associated with substantial mortality and use of health care resources …
(COVID-19) is associated with substantial mortality and use of health care resources …
American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated With SARS–CoV‐2 and hyperinflammation in …
LA Henderson, SW Canna, KG Friedman… - Arthritis & …, 2020 - Wiley Online Library
Objective To provide guidance on the management of multisystem inflammatory syndrome
in children (MIS‐C), a condition characterized by fever, inflammation, and multiorgan …
in children (MIS‐C), a condition characterized by fever, inflammation, and multiorgan …
American College of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS–CoV‐2 and Hyperinflammation in …
LA Henderson, SW Canna, KG Friedman… - Arthritis & …, 2021 - Wiley Online Library
Objective To provide guidance on the management of Multisystem Inflammatory Syndrome
in Children (MIS‐C), a condition characterized by fever, inflammation, and multiorgan …
in Children (MIS‐C), a condition characterized by fever, inflammation, and multiorgan …
Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
Y Yang, C Shen, J Li, J Yuan, J Wei, F Huang… - Journal of Allergy and …, 2020 - Elsevier
Background The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 was first reported in Wuhan, December 2019, and …
acute respiratory syndrome coronavirus 2 was first reported in Wuhan, December 2019, and …
[HTML][HTML] Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak …
TM Uyeki, HH Bernstein, JS Bradley… - Clinical Infectious …, 2019 - academic.oup.com
These clinical practice guidelines are an update of the guidelines published by the
Infectious Diseases Society of America (IDSA) in 2009, prior to the 2009 H1N1 influenza …
Infectious Diseases Society of America (IDSA) in 2009, prior to the 2009 H1N1 influenza …
Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome
The outbreak of Coronavirus Disease 2019 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, December 2019 …
respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, December 2019 …
Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome
YM Arabi, Y Mandourah, F Al-Hameed… - American journal of …, 2018 - atsjournals.org
Rationale: Corticosteroid therapy is commonly used among critically ill patients with Middle
East Respiratory Syndrome (MERS), but its impact on outcomes is uncertain. Analyses of …
East Respiratory Syndrome (MERS), but its impact on outcomes is uncertain. Analyses of …
Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and …
BACKGROUND: Very little direct evidence exists on use of corticosteroids in patients with
coronavirus disease 2019 (COVID-19). Indirect evidence from related conditions must …
coronavirus disease 2019 (COVID-19). Indirect evidence from related conditions must …